In addition, the fact that EphA2 KD in MDA‐MB‐231 tumor cells phenocopies expression of the dominant negative mutant capable of mediating reverse signaling in  4T1 tumor cells also provides support for this model. This evidence concerns the gene EPHA2 and neoplasm.